Podocytopathies associated with familial partial lipodystrophy due to LMNA variants: report of two cases

被引:0
|
作者
Morguetti, Maria Julia [1 ]
Neves, Precil Diego Miranda de Menezes [2 ]
Korkes, Ilana [1 ]
Padilha, Wallace Stwart Carvalho [3 ]
Jorge, Lecticia Barbosa [4 ]
Watanabe, Andreia [5 ]
Watanabe, Elieser Hitoshi [2 ]
Malheiros, Denise Maria Avancini Costa [6 ]
Noronha, Irene de Lourdes [4 ]
Dib, Sergio Atala [1 ]
Onuchic, Luiz Fernando [7 ]
Moises, Regina S. [1 ]
机构
[1] Univ Fed Sao Paulo, Div Endocrinol, Escola Paulista Med, Sao Paulo, SP, Brazil
[2] Univ Sao Paulo, Fac Med, Divisoes Nefrol & Med Mol, Sao Paulo, SP, Brazil
[3] Univ Fed Sao Paulo, Escola Paulista Med, Div Nefrol, Sao Paulo, SP, Brazil
[4] Univ Sao Paulo, Fac Med, Div Nefrol, Sao Paulo, SP, Brazil
[5] Univ Sao Paulo, Fac Med, Div Nefrol Pediat & Med Mol, Sao Paulo, SP, Brazil
[6] Univ Sao Paulo, Fac Med, Dept Patol, Sao Paulo, SP, Brazil
[7] Univ Sao Paulo, Fac Med, Dept Clin Med, Sao Paulo, SP, Brazil
来源
关键词
ACQUIRED PARTIAL LIPODYSTROPHY; PHENOTYPIC DIVERSITY; LAMIN A/C; LMNA; GLOMERULOSCLEROSIS; MUTATION; DISEASE;
D O I
10.20945/2359-4292-2023-0204
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Lipodystrophies are characterized by complete or selective loss of adipose tissue and can be acquired or inherited. Familial partial lipodystrophy (FPLD) is a hereditary lipodystrophy commonly caused by mutations in the LMNA gene. Herein, we report two cases of FPLD associated with podocytopathies. Patient 1 was diagnosed with FPLD associated with the heterozygous p.Arg482Trp variant in LMNA and had normal glucose tolerance and hyperinsulinemia. During follow-up, she developed nephroticrange proteinuria. Renal biopsy was consistent with minimal change disease. Patient 2 was diagnosed with FPLD associated with a de novo heterozygous p.Arg349Trp variant in LMNA . Microalbuminuria progressed to macroalbuminuria within 6 years and to nephrotic range proteinuria in the last year. He remained without diabetes and with hyperinsulinemia. Renal biopsy revealed focal segmental glomerulosclerosis not otherwise specified. This report provides further evidence of variable features of lipodystrophy associated with LMNA variants and the importance of long-term follow-up with evaluation of kidney dysfunction.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Familial Partial Lipodystrophy, Importance of Family History - A Case Report
    Stockley, Camilla
    Holder, Susan
    Rangasami, Jayanti
    HORMONE RESEARCH IN PAEDIATRICS, 2018, 90 : 337 - 337
  • [42] Management challenges in familial partial lipodystrophy (FPLD): A case report
    Lessan, N.
    Moriarty, M.
    Suliman, S. G. I.
    Naqvi, S.
    DIABETIC MEDICINE, 2019, 36 : 88 - 88
  • [43] A case of Dunnigan-type familial partial lipodystrophy (FPLD) due to lamin A/C (LMNA) mutations complicated by end-stage renal disease
    Imachi, Hitomi
    Murao, Koji
    Ohtsuka, Shouji
    Fujiwara, Mako
    Muraoka, Tomie
    Hosokawa, Hitoshi
    Ishida, Toshihiko
    ENDOCRINE, 2009, 35 (01) : 18 - 21
  • [44] A case of Dunnigan-type familial partial lipodystrophy (FPLD) due to lamin A/C (LMNA) mutations complicated by end-stage renal disease
    Hitomi Imachi
    Koji Murao
    Shouji Ohtsuka
    Mako Fujiwara
    Tomie Muraoka
    Hitoshi Hosokawa
    Toshihiko Ishida
    Endocrine, 2009, 35 : 18 - 21
  • [45] Deciphering the Clinical Presentations in LMNA-related Lipodystrophy: Report of 115 Cases and a Systematic Review
    Besci, Ozge
    de Freitas, Maria Christina Foss
    Guidorizzi, Natalia Rossin
    Guler, Merve Celik
    Gilio, Donatella
    Maung, Jessica N.
    Schill, Rebecca L.
    Hoose, Keegan S.
    Obua, Bonje N.
    Gomes, Anabela D.
    Simsir, Ilgin Yildirim
    Demir, Korcan
    Akinci, Baris
    MacDougald, Ormond A.
    Oral, Elif A.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (03): : e1204 - e1224
  • [46] Efficacy of pioglitazone in familial partial lipodystrophy of the Dunnigan type: a case report
    Moreau, F.
    Boullu-Sanchis, S.
    Vigouroux, C.
    Lucescu, C.
    Lascols, O.
    Sapin, R.
    Ruimy, D.
    Guerci, B.
    Pinget, M.
    Jeandidier, N.
    DIABETES & METABOLISM, 2007, 33 (05) : 385 - 389
  • [47] Diagnostic Challenge in PLIN1-Associated Familial Partial Lipodystrophy
    Jeru, Isabelle
    Vantyghem, Marie-Christine
    Bismuth, Elise
    Cervera, Pascale
    Barraud, Sara
    Devemy, Fabrice
    Karrouz, Wassila
    Haye, Sophie
    Janmaat, Sonja
    Delemer, Brigitte
    Meggison, Hilary
    Geraghty, Michael T.
    Auclair, Martine
    Vatier, Camille
    Lascols, Olivier
    Savage, David B.
    Vigouroux, Corinne
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (12): : 6025 - 6032
  • [48] A cohort analysis of familial partial lipodystrophy from two Mediterranean countries
    Fernandez-Pombo, Antia
    Simsir, Ilgin Yildirim
    Sanchez-Iglesias, Sofia
    Ozen, Samim
    Castro, Ana I.
    Atik, Tahir
    Loidi, Lourdes
    Onay, Huseyin
    Prado-Morana, Teresa
    Adiyaman, Cem
    Diaz-Lopez, Everardo Josue
    Altay, Canan
    Ginzo-Villamayor, Maria Jose
    Akinci, Baris
    Araujo-Vilar, David
    DIABETES OBESITY & METABOLISM, 2024, 26 (11): : 4875 - 4886
  • [49] Atypical Progeroid Syndrome and Partial Lipodystrophy Due to LMNA Gene p.R349W Mutation
    Magno, Silvia
    Ceccarini, Giovanni
    Pelosini, Caterina
    Ferrari, Federica
    Prodam, Flavia
    Gilio, Donatella
    Maffei, Margherita
    Sessa, Maria Rita
    Barison, Andrea
    Ciccarone, Annamaria
    Emdin, Michele
    Aimaretti, Gianluca
    Santini, Ferruccio
    JOURNAL OF THE ENDOCRINE SOCIETY, 2020, 4 (10)
  • [50] Novel LMNA mutations seen in patients with familial partial lipodystrophy subtype 2 (FPLD2;: MIM 151660)
    Lanktree, M.
    Cao, H.
    Rabkin, S. W.
    Hanna, A.
    Hegele, R. A.
    CLINICAL GENETICS, 2007, 71 (02) : 183 - 186